Aurobindo Pharma Limited is a large cap pharmaceutical company belonging to Nifty 50 group of companies. The Aurobindo Pharma share price reflects the current financial status of the company.
Live Stock Quote: Unfortunately, we could not get stock quote NSE:AUROPHARMA this time.
Aurobindo Pharma Share Price Graph
About the company – Incorporated by K.Nityananda Reddy and P.V. Ramaprasad Reddy in 1986 it started a business by manufacturing SSP (semi-synthetic penicillin) from a single manufacturing unit situated at Puducherry (then Pondicherry). Aurobindo Pharma has a presence across key segments of IPM. Segments like CNS, antivirals, cephalosporins, SSP, gastroenterology, cardio – vascular bear strong footprint of Aurobindo Pharma. They are the market leader in which they started their operation back in 1986, i.e. SSP drugs.
It also has a strong global presence. It earns revenue from drugs sold at Ethiopia, Ghana, Tanzania, Uganda, Kenya, Vietnam, Italy and UK for which it has set up branches or representative offices in the abovementioned countries. Aurobindo Pharma Limited has a strong global presence and its products are sold in more than 100 countries. The company and its subsidiaries have marketing and/ or manufacturing units in China, Japan, Thailand, Brazil, South Africa, UK, USA, Russia, Netherlands. They company has plans to expand its business to other countries as well which are not yet in the network.
Much of its financials resources are invested in building huge infrastructure for the APIs to make Aurobindo Pharma a vertically integrated pharmaceutical major. The drugs manufactured at different plants has approval from major international bodies like WHO, USFDA, UK MHRA, MCC-SA, ANVISA – BRAZIL . Through merger and acquisition, it acquired Actavis plc in 2014 to extends its operation in Western Europe.
The company has received many awards for excellence in drug manufacturing field.
Company Financials – Aurobindo Pharma share price is Rs 652.65 (as on 16.06.17, EOD) in BSE. As per latest data, the standalone basis P/E is 22.08 versus average industry PE of 28.7, EPS is Rs 29.13. Market cap is Rs 37,684 crores. The face value of a share is Rs 1.
For more information on other companies, kindly visit our page.